Neurology · 2004 · 11 citations · 9 references
MedicineGeneticsMolecular GeneticsEpilepsyNeurogeneticsPharmacogeneticsEpilepsy GeneticsEtiology Of EpilepsyGenetic EpilepsiesMolecular NeurogeneticsNeurogenetic DisordersPopulation PharmacogeneticsGenetic Causes Of EpilepsyPharmacogenetics In Epilepsy
Dopamine beta-hydroxylase (DBH) catalyzes the conversion of dopamine to norepinephrine (NE). Animal studies show that genes in the NE pathway are candidates for susceptibility to epilepsy and antiepileptic drug (AED) response. The authors genotyped the -1021C-->T major functional polymorphism in the DBH gene in 675 patients with epilepsy and 1,087 controls. The authors found no association with epilepsy, several epilepsy subtypes, or AED response. The results suggest that the -1021C-->T variant does not contribute to epilepsy.
9
Proposal for Revised Classification of Epilepsies and Epileptic Syndromes
Epilepsia · 1989 · 5.4K citations
Medicine, Neurology, Neuroscience +12
Cyrus P. Zabetian, George Anderson, Sarah G. Buxbaum et al. · The American Journal of Human Genetics · 2001 · 270 citations · Full text
Mechanisms of antiepileptic drug resistance
Sanjay M. Sisodiya · Current Opinion in Neurology · 2003 · 143 citations
Medicine, Neurology, Pharmacology +14